A 42-year-old woman from Virginia, USA, presents with a 5-day history of fever (39.2°C), severe frontal headache, and myalgia. On examination, she has a petechial rash that began on her wrists and ankles 2 days ago and has now spread to involve the trunk, including the palms and soles. She reports a tick bite on her leg 8 days ago while hiking. Platelet count is 95,000/μL (mild thrombocytopenia). What is the most likely diagnosis?

Explanation

## Clinical Diagnosis: Rocky Mountain Spotted Fever (RMSF) ### Key Clinical Features Pointing to RMSF **Key Point:** The **characteristic centripetal rash** (wrists/ankles → trunk, including palms and soles) in a tick-exposed patient from an endemic region is pathognomonic for RMSF. **High-Yield:** RMSF is caused by *Rickettsia rickettsii*, transmitted by *Dermacentor* ticks (American dog tick, Rocky Mountain wood tick). It is the most common rickettsial infection in North America and has the highest mortality among rickettsial diseases if untreated (20–30%). ### Pathophysiology & Epidemiology 1. **Causative agent:** *Rickettsia rickettsii* — obligate intracellular gram-negative coccobacillus 2. **Vector:** *Dermacentor* ticks (mainly *D. variabilis* in eastern USA, *D. andersoni* in western USA) 3. **Geographic distribution:** Primarily North America (USA, Canada, Mexico); highest incidence in south-central and southeastern USA 4. **Transmission:** Tick bite; spirochetes in tick saliva enter host during feeding (typically requires ≥6 hours of attachment) 5. **Incubation period:** 2–14 days (average 7 days) — consistent with this patient's 8-day exposure ### Clinical Presentation & Rash Pattern **Mnemonic:** **"RMSF = Rash from Wrists to Soles"** | Feature | RMSF | Scrub Typhus | Murine Typhus | |---------|------|--------------|----------------| | **Rash onset** | Day 2–4 of fever | Day 4–6 of fever | Day 5–8 of fever | | **Rash distribution** | Wrists/ankles → trunk; **includes palms/soles** | Trunk → limbs; **spares palms/soles** | Trunk; spares palms/soles | | **Rash type** | Maculopapular → petechial | Maculopapular | Maculopapular | | **Eschar** | Absent | Present (tache noire) | Absent | | **Lymphadenopathy** | Absent | Regional (prominent) | Absent | | **Tick exposure** | Yes (*Dermacentor*) | No (mite bite) | No (flea bite) | | **Geographic risk** | North America | Tsutsugamushi Triangle | Worldwide (urban) | **Clinical Pearl:** The **centripetal rash pattern** (starting at extremities and spreading inward) is the hallmark of RMSF. Involvement of palms and soles is highly specific and distinguishes RMSF from scrub typhus and murine typhus. ### Systemic Manifestations - **Constitutional:** Fever, severe headache, myalgia, malaise - **Cutaneous:** Petechial rash (may become purpuric in severe cases) - **Hematologic:** Thrombocytopenia (50–100,000/μL in 30–50% of cases), as seen in this patient - **Vascular:** Endothelial injury → increased vascular permeability → edema, hypotension - **Severe complications:** ARDS, acute kidney injury, myocarditis, DIC, gangrene (in untreated cases) ### Diagnosis - **Serology:** Weil-Felix test (positive but non-specific), IgM/IgG antibodies (positive from day 7–10 onwards) - **Immunohistochemistry:** Gold standard — direct fluorescent antibody staining of skin biopsy or eschar - **PCR:** Real-time PCR on blood or tissue - **Culture:** Difficult; BSL-3 facility required **Warning:** Do NOT wait for serology confirmation — clinical diagnosis + tick exposure + rash pattern warrant immediate empiric treatment. ### Treatment **High-Yield:** Doxycycline is the **drug of choice** and should be started immediately on clinical suspicion. - **First-line:** Doxycycline 100 mg BD for 7–14 days (even in children <8 years if RMSF is suspected — benefit outweighs tetracycline staining risk) - **Alternative (pregnancy/allergy):** Chloramphenicol 500 mg QID for 7–14 days - **Pediatric:** Doxycycline preferred over chloramphenicol due to better CNS penetration **Clinical Pearl:** Early treatment (within 5 days of symptom onset) dramatically reduces mortality from 20% to <5%. Delayed treatment is the leading cause of death in RMSF. ### Why RMSF (Not the Others)? The **centripetal rash involving palms and soles** is the key discriminator. Scrub typhus presents with a centrifugal rash (trunk → limbs) that **spares palms/soles** and includes an eschar. Ehrlichiosis typically lacks a rash. Lyme disease presents with erythema migrans (expanding annular lesion) at the bite site, not a generalized petechial rash.